Why the study?
Does resection improve outcomes in patients with relapsed retroperitoneal sarcoma?
Does resection improve outcomes in patients with relapsed retroperitoneal sarcoma?
Patients with locally recurrent or metastatic retroperitoneal sarcoma should be considered for resection due to high disease-specific mortality.
Answers are grounded in this paper and cite their sources.
May support resection in relapsed RPS; leaves open survival benefit versus observation pending prospective data.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
MacNeill et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: